David Einhorn’s Interview: Tech is a Smaller Bubble

Billionaire David Einhorn, is the manager of Greenlight Capital, a hedge fund with over $10 billion in Assets Under Management. In a recent interview with Bloomberg Television’s Stephanie Ruhle and Erik Schatzker, Mr. Einhorn was asked regarding his opinion on technology stocks, Federal Reserve’s policies, investment strategies, as well as other matters. The manager of Greenlight emphasized that he is fond of technology stocks, as he considers the Technology sector to be a smaller bubble, which doesn’t involve all technology companies. This is also confirmed by taking a look at Greenlight’s equity portfolio, in which the first two positions are represented by Apple Inc. (NASDAQ:AAPL) and Micron Technology, Inc. (NASDAQ:MU) (see the full list of Einhorn’s picks here).

“[...]we think that there’s a sub-segment of tech which is high momentum stocks that have gotten completely out of control in terms of their valuation, and we think that those stocks actually did reach sort of a bubble proportion,” Mr. Einhorn stated.

David Einhorn

Einhorn also discussed his short position on athenahealth, Inc (NASDAQ:ATHN), revealed yesterday during Ira Sohn conference., saying that he considers it a good company, with a good strategy and a good management, but its stock is overpriced. The stock of athenahealth, a company that provides clinical-related services through a Web-based currently trades down 20% year-to-date, dropping by around 15% on Tuesday.

“And what happened was is a few weeks ago Morgan Stanley came out with this conventional DCF valuation where they projected out the results until 2030 and we just looked at that and said, wow, how are you going to get from a 10 percent margin before the stock comp to a 30 percent margin? And we thought about the business, and we just don’t think that the assumptions that they’re using there are plausible.”

Another company mentioned by Einhorn was King Digital Entertainment PLC (NYSE:KING), a company that went public around a month ago, whose stock declined right after the IPO, and is currently down over 1%. The manager of Greenlight Capital said among other things that with the IPOs, investors are buying shares of these companies  ”without thinking too much about them because they were going up 40 percent the next day or 30 percent the next day.”

“We like to get our analysis right and sometimes just wait longer than other people, and that’s one of the things that — our horizon for investments is not usually a day or a week or a month. We tend to on the long side be really one to four years, which is ancient on Wall Street these days particularly with hedge funds.”

Einhorn also expressed his ideas regarding the current chairman of the Federal Reserve, Janet Yellen. He said that he would like to “keep an open mind.” In his point of view, Yellen has been approaching problems right and that he would like to see if “she has a better reason why rates should remain at zero at this stage in the economy.”

if you start at a zero rate and you start with a huge amount — huge balance sheet and the economy turns down, the available tools that they will have are limited and there’s a risk that they will have to choose a tradeoff between doing something exceedingly aggressive, right, versus allowing a — a crisis situation to fester. And they might choose to do something exceedingly aggressive and it may have a — that 1 percent outcome.”

The full video of Einhorn’s interview on Bloomberg Television can be watched below:

Disclosure: none

Recommended Reading:

Greenlight Capital 2014 Q1 Investor Letter (See also our hedge fund investor letters group)

Avoid David Einhorn’s Large Cap Stock Picks

David Einhorn, Greenlight Capital Raise Stake in BioFuel Energy Corp. (BIOF); Send Business Proposal To Board

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!